Finance

Lists
Why is 6541 down 2.89%?
Dive Deeper
6541:TPE
Tanvex Biopharma Inc
NT$26.90
-2.89%
(-0.80) 1D
Nov 5, 1:30:02 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6541...
Open
NT$28.10
High
NT$28.80
Low
NT$26.85
Mkt. cap
7.13B
Avg. vol.
477.19K
Volume
605.97K
52-wk high
NT$65.50
52-wk low
NT$26.05
EPS
-NT$5.56
Shares outstanding
242.67M
No. of employees
215
Open
NT$28.10
High
NT$28.80
Low
NT$26.85
Mkt. cap
7.13B
Avg. vol.
477.19K
Volume
605.97K
52-wk high
NT$65.50
52-wk low
NT$26.05
EPS
-NT$5.56
Shares outstanding
242.67M
No. of employees
215
News stories
From web sources and news partners
About Tanvex Biopharma Inc
CEO-
Employees215
Founded2011
Headquarters-
SectorBiotechnology
Industry-
Websitetanvex.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
125.34M
178.95M
132.83M
220.44M
Cost of goods sold
287.65M
422.66M
399.36M
446.37M
Cost of revenue
287.65M
422.66M
399.36M
446.37M
Research and development expenses
19.27M
13.26M
24.24M
19.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104.56M
104.26M
108.51M
121.17M
Operating expense
123.98M
129.86M
133.70M
141.15M
Total operating expenses
411.63M
552.52M
533.06M
587.52M
Operating income
-286.29M
-373.57M
-400.23M
-367.07M
Other non operating income
-372.00K
44.99M
188.00K
418.00K
EBT including unusual items
-273.50M
-420.53M
-388.70M
-382.53M
EBT excluding unusual items
-294.27M
-305.62M
-388.70M
-382.53M
Income tax expense
-
3.00K
27.00K
1.00K
Effective tax rate
-
-
-0.01%
-
Other operating expenses
-
-
-
-
Net income
-273.50M
-420.54M
-388.72M
-382.53M
Net profit margin
-218.21%
-235.00%
-292.65%
-173.53%
Earnings per share
-
-
-
-
Interest and investment income
7.83M
11.66M
6.03M
5.01M
Interest expense
-11.41M
-11.31M
-11.70M
-16.53M
Net interest expenses
-3.58M
354.00K
-5.67M
-11.52M
Depreciation and amortization charges
-
-
-
-
EBITDA
-243.08M
-370.64M
-357.68M
-326.85M
Gain or loss from assets sale
-21.83M
62.12M
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps